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Protease-activated receptor-1 (PAR1), a G protein-
coupled receptor (GPCR) for thrombin, is irreversibly
proteolytically activated, internalized, and then sorted
to lysosomes and degraded. Internalization and lysoso-
mal sorting of activated PAR1 is critical for termination
of receptor signaling. We previously demonstrated that
activated PAR1 is rapidly phosphorylated and internal-
ized via a clathrin- and dynamin-dependent pathway
that is independent of arrestins. Toward understanding
the mechanisms responsible for activated PAR1 inter-
nalization through clathrin-coated pits we examined the
function of a highly conserved tyrosine-based motif,
YXXL, localized in the cytoplasmic carboxyl tail of the
receptor. A mutant PAR1 in which tyrosine 383 and
leucine 386 were replaced with alanines (Y383A/L386A)
was significantly impaired in agonist-triggered inter-
nalization and degradation compared with wild-type re-
ceptor. In contrast, constitutive internalization, and re-
cycling of unactivated PAR1 Y383A/L386A mutant was
not affected, suggesting that tonic cycling of the mutant
receptor remained intact. Strikingly, a PAR1 C387Z
truncation mutant in which the YXXL motif was exposed
at the C terminus constitutively internalized and de-
graded in an agonist-independent manner, whereas
C387Z truncation mutant in which the critical tyrosine
and leucine were mutated to alanine (C387Z-Y383A/
L386A) failed to internalize. Inhibition of PAR1 C387Z
mutant constitutive internalization with dominant-neg-
ative K44A dynamin blocked agonist-independent deg-
radation of the mutant receptor. Together these find-
ings strongly suggest that internalization of activated
PAR1 is controlled by multiple regulatory mechanisms
involving phosphorylation and a highly conserved ty-
rosine-based motif, YXXL. This study is the first to de-
scribe a function for a tyrosine-based motif, YXX, in
GPCR internalization and reveal novel complexities in
the regulation of GPCR trafficking.
Trafficking of activated G protein-coupled receptors
(GPCRs)1 is a regulated process important in signal termina-
tion, receptor resensitization, and down-regulation. Upon acti-
vation, GPCRs are rapidly phosphorylated by G protein-cou-
pled receptor kinases, which facilitates the binding of arrestins
to intracellular domains of the receptor (1). Arrestin binding
not only serves to functionally uncouple the receptor from G
proteins as part of the desensitization process, but also pro-
motes internalization of the receptor through direct and indi-
rect interactions with components of the clathrin endocytic
machinery (2). In many cases, agonist dissociates from the
GPCR within endosomes; the receptor is then dephosphoryl-
ated and returned to the plasma membrane in a resensitized
state competent to signal again. The trafficking of internalized
GPCRs from endosomes to lysosomes also contributes to recep-
tor down-regulation, another important process for signal ter-
mination (3). The mechanisms involved in down-regulation of
GPCRs by internalization and lysosomal sorting are not clearly
understood.
Protease-activated receptor 1 (PAR1), a GPCR for the coag-
ulant protease thrombin, is the predominant mediator of
thrombin-elicited cellular responses. PAR1 is activated by an
unusual irreversible proteolytic event, whereby thrombin binds
to and cleaves the N-terminal exodomain of the receptor. This
cleavage exposes a new N terminus that acts as a tethered
ligand by binding intramolecularly to the body of the receptor
to cause transmembrane signaling (4–6). The synthetic pep-
tide SFLLRN, that mimics the first six residues of the newly
formed N terminus, can fully activate PAR1 independent of
thrombin and receptor cleavage. Despite the irreversible pro-
teolytic mechanism of PAR1 activation, signaling by the recep-
tor is rapidly terminated. The extent of thrombin-induced sig-
naling responses precisely correlate with the absolute rate of
receptor cleavage during a given time (7), suggesting that each
activated PAR1 signals, generates a defined amount of second
messenger, and then shuts off. This places particular impor-
tance on the mechanisms that contribute to the termination of
PAR1 signaling. The desensitization, internalization, and
down-regulation processes of irreversibly proteolytically acti-
vated PAR1 signaling is poorly understood. Given the irrevers-
ible nature of PAR1 activation, we hypothesize that signal
termination mechanisms are likely unique.
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In most cell types, PAR1 resides both on the cell surface and
in an intracellular compartment (8–10), due in part to two
distinct modes of receptor trafficking. Unactivated PAR1 cycles
constitutively between the cell surface and an intracellular
pool. This provides an intracellular store of uncleaved recep-
tors, which allows for rapid repopulation of the cell surface with
naive receptors following thrombin exposure. After activation
with thrombin or peptide agonist SFLLRN, PAR1 is internal-
ized, sorted predominantly to lysosomes and degraded (8, 11). A
PAR1 mutant in which all of the serines and threonines, po-
tential sites of phosphorylation, in the cytoplasmic carboxyl tail
(C-tail) were mutated to alanines was defective in agonist-
stimulated internalization and degradation, whereas constitu-
tive cycling of unactivated receptor remained intact (10). In
contrast, a mutant PAR1 in which residues between positions
397 and 406 within the C-tail were converted to alanine or
glycine displayed normal internalization and lysosomal sorting
when activated, but failed to tonically cycle in the absence of
agonist (12). These findings imply that separate signals regu-
late the distinct trafficking behaviors of unactivated and acti-
vated PAR1. Thus, the irreversible proteolytic nature of PAR1
activation may have necessitated an unusual pattern of recep-
tor trafficking.
Phosphorylation of activated PAR1 is one important compo-
nent for rapid desensitization of receptor signaling and inter-
nalization from the plasma membrane (10). We recently found
that arrestin interaction with PAR1 also plays a critical role in
uncoupling activated receptor from G protein signaling (13, 14).
Internalization and lysosomal sorting of activated PAR1 is
another important process that mediates termination of recep-
tor signaling. Our previous work demonstrated in fibroblasts
that a PAR1 chimera containing the C-tail of the substance P
receptor (P/S C-tail), a GPCR that internalizes and recycles
back to the cell surface, showed enhanced and prolonged sig-
naling after activation with thrombin (11, 15). This prolonged
signaling was apparently due to recycling and continued sig-
naling by receptors that returned to the cell surface with their
tethered ligands intact. Thus, the C-tail of PAR1 specifies an
intracellular sorting pattern that is linked to its signaling
properties. In contrast to most classic GPCRs, sorting of acti-
vated PAR1 to lysosomes rather than recycling is critical for
termination of receptor signaling.
Activated PAR1 is internalized via a clathrin- and dynamin-
dependent pathway based on our previous findings that acti-
vated PAR1 is rapidly recruited to clathrin-coated pits and
internalization is blocked by dominant-negative dynamin and
clathrin hub mutants (16). These observations, together with
the phosphorylation dependence of PAR1 trafficking (10),
raised the possibility that arrestins function in PAR1 internal-
ization. However, we recently found that activated PAR1 is
internalized through a clathrin- and dynamin-dependent path-
way independent of arrestins (13). In mouse embryonic fibro-
blasts lacking both arrestin isoforms, termination of activated
PAR1 signaling is impaired; however, agonist-induced inter-
nalization and lysosomal sorting of PAR1 is unaffected. These
findings indicate that activated PAR1 internalization occurs
via an arrestin-independent pathway, whereas regulation of
receptor G protein coupling is clearly arrestin-dependent. Al-
though arrestins are not essential for PAR1 internalization,
C-tail phosphorylation of activated receptor was still required
for this process. Thus, PAR1 defines a new class of GPCRs:
receptors that use a phosphorylation-, clathrin-, and dynamin-
dependent endocytic pathway that is independent of arrestins.
The mechanism by which activated PAR1 is recruited to clath-
rin-coated pits is not known.
We hypothesize that PAR1 internalization through clathrin-
coated pits is controlled by multiple regulatory mechanisms.
The first involves phosphorylation of the C-tail that occurs at
multiple alternative sites (17), any of which is sufficient for
internalization. The second involves interaction with an adap-
tor protein (other than arrestins) that presumably binds to a
sorting sequence present in the C-tail of PAR1 and recruits the
receptor to clathrin-coated pits. In the present study we exam-
ined the regulation of PAR1 trafficking by a highly conserved
tyrosine-based motif localized in the C-tail region of the recep-
tor. Our findings strongly suggest that in addition to C-tail
phosphorylation, a tyrosine-based sorting signal also regulates
agonist-induced PAR1 internalization. These findings reveal a
novel type of mechanism by which GPCRs can internalize
through clathrin-coated pits.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies—Human -thrombin was purchased from
Enzyme Research Laboratories. Agonist peptide SFLLRN was synthe-
sized as the carboxyl amide and purified by reverse phase high-pressure
liquid chromatography (UNC Peptide Facility, Chapel Hill, NC). Hiru-
din was obtained from Sigma Chemical Co. [myo-3H]Inositol was pur-
chased from American Radiolabelled Chemicals Inc.
Monoclonal M1 and M2 anti-FLAG antibodies were purchased from
Sigma Chemical Co. Rabbit anti-PAR1 polyclonal antibody was gener-
ated as previously described (18). Horseradish peroxidase-conjugated
goat anti-mouse and anti-rabbit secondary antibodies were from Bio-
Rad. 125I-Goat anti-mouse IgG was from American Radiolabelled Chem-
icals Inc.
cDNAs and Cell Lines—A cDNA encoding wild-type PAR1 containing
an N-terminal FLAG epitope has been previously described (19). PAR1
mutants were generated from full-length cDNA using QuikChangeTM
site-directed mutagenesis kit (Stratagene), and specific mutations were
confirmed by dideoxy sequencing. A PAR1 cDNA containing the sub-
stance P receptor cytoplasmic tail (P/S C-tail) has been described pre-
viously (11). The plasmids encoding green fluorescence protein (GFP)-
tagged wild-type and dominant-negative (K44A) dynamin (Dyn) were
kindly provided by M. A. McNiven, (Mayo Clinic and Foundation).
HeLa cells were maintained in DMEM supplemented with 10% fetal
bovine serum, 4.5 mg/ml glucose, 100 units/ml penicillin, and 100
g/ml streptomycin.
HeLa cells were plated at 8  104, 1.5  105, or 2.5  105 cells per
well of 24-, 12-, or 6-well plates, respectively, and grown overnight.
Cells were then transiently transfected with a total of 0.4, 0.8, or 2 g
per well of 24-, 12-, or 6-well plates, respectively, of plasmids encod-
ing FLAG-tagged PAR1 wild-type or mutants and either pcDNA
vector, GFP-Dyn wild-type or K44A mutant using LipofectAMINE
Reagent (Invitrogen) according to the manufacturer’s instructions.
Internalization Assays—To follow the loss of cell surface FLAG-
tagged receptors, transiently transfected HeLa cells plated on fibronec-
tin-coated 24- or 12-well culture dishes (Falcon) were incubated with or
without agonist for various times at 37 °C. Cells were fixed with 4%
paraformaldehyde for 5 min at 4 °C, washed, and then incubated with
M1 anti-FLAG antibody diluted in DMEM containing 1 mg/ml BSA, 1
mM CaCl2, 10 mM HEPES, pH 7.4 for 1 h at 25 °C. Cells were washed
and then incubated with either 125I-labeled goat anti-mouse secondary
antibody or horseradish peroxidase-conjugated goat anti-mouse second-
ary antibody for an additional 1–2 h at 25 °C. In the latter case, the
amount of bound horseradish peroxidase-goat anti-mouse secondary
antibody was determined by incubation with 1-Step ABTS (2,2-azino-
bis-3-ethylbenz-thiazoline-6-sulfonic acid) (Pierce) substrate for 10–20
min at 25 °C. An aliquot was removed, and the optical density deter-
mined at 405 nm using a Molecular Devices SpectraMax Plus micro-
plate reader. To detect the amount of surface bound 125I-labeled goat
anti-mouse secondary antibody, cells were lysed with 1 N NaOH, and
the amount of radioactivity present in lysates was determined with a
 counter.
To follow the cohort of internalized receptors, HeLa cells transiently
expressing similar amounts of FLAG-PAR1 wild type or mutants were
incubated with the calcium-dependent M1 anti-FLAG antibody for 1 h
at 4 °C. Under these conditions only receptors present on the cell
surface bind antibody. Cells were washed and incubated in the absence
or presence of agonist for various times at 37 °C. Surface-bound anti-
body was then removed by three washes with PBS, Ca2- and Mg2-
free, containing 0.04% EDTA for 5 min at 4 °C. Cells were then lysed in
Triton lysis buffer (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM EDTA,
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3% BSA, and 1% Triton X-100), and accumulated intracellular antibody
was measured by ELISA as previously described (10).
To assess recovery of internalized receptors, HeLa cells transiently
expressing similar amounts of surface FLAG-tagged PAR1 wild type or
mutants were incubated with M1 anti-FLAG antibody for 1 h at 4 °C.
Cells were washed to remove unbound antibody and then incubated in
the absence or presence of agonist for 90 min at 37 °C. The remaining
surface-bound antibody was then removed with PBS, 0.04% EDTA, and
the amount of receptor-bound antibody reappearing at the cell surface
was measured by ELISA as described previously (11).
Immunoblotting—HeLa cells plated in 6-well culture dishes (Falcon)
transiently expressing FLAG-tagged PAR1 wild type or mutants were
lysed in Triton lysis buffer (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM
EDTA, 50 mM NaF, 10 mM sodium pyrophosphate, 200 M sodium
orthovanadate, and 1% Triton-X-100) containing protease inhibitors.
An equivalent amount of lysates was then used for immunoprecipita-
tion with M2 anti-FLAG antibody. Immunoprecipitates were resolved
by SDS-PAGE, transferred, and immunoblotted with anti-PAR1 anti-
body followed by secondary antibody conjugated to horseradish perox-
idase. Immunoblots were developed with ECL-PLUSTM (Amersham
Biosciences, Inc.), imaged by autoradiography, and quantitated by a
BioRad Fluor-S MultiImager.
Phosphoinositide Hydrolysis—HeLa cells plated in 12-well dishes
transiently expressing FLAG-PAR1 wild type or mutants were labeled
with 2 Ci/ml of [myo-3H]inositol in serum-free DMEM containing 1
mg/ml BSA overnight. Cells were washed and then incubated in the
absence or presence of agonist diluted in DMEM, 1 mg/ml BSA contain-
ing 20 mM lithium chloride for various times at 37 °C. Cell incubation
medium was removed, and total cellular [3H]inositol phosphates
([3H]IPs) were extracted, isolated, and quantitated as described previ-
ously (13).
Data Analysis—Data were analyzed using Prism 3.0 Software, and
statistical significance was determined using InStat 3.0 (GraphPAD,
San Diego, CA).
RESULTS
Expression and Signaling of PAR1 Y383A/L386A Mutant—
We previously demonstrated that activated PAR1 internaliza-
tion occurs through a clathrin- and dynamin-dependent path-
way that is independent of arrestins (13, 16). Interestingly,
however, agonist-induced phosphorylation of PAR1 C-tail do-
main is necessary for internalization of the receptor, even in
the absence of arrestins. Toward identifying the mechanism
responsible for recruitment and internalization of activated
PAR1 through clathrin-coated pits, we examined the C-tail
region for conserved amino acid residues that might function as
intracellular sorting signals. Amino acid sequence alignment of
the PAR1 C-tail regions from all known species revealed the
presence of a highly conserved tyrosine-based motif, YXXL,
which localized approximately ten amino acids from the end of
the seventh transmembrane domain (Fig. 1A). In contrast,
examination of the C-tail region of the 2-adrenergic receptor,
a GPCR that requires arrestins for internalization (20), failed
to reveal such a motif.
To begin to investigate the function of these conserved resi-
dues in PAR1 trafficking we generated a mutant PAR1 in
which tyrosine 383 and leucine 386 were converted to alanines
(Y383A/L386A). We first determined whether PAR1 Y383A/
L386A mutant was expressed at the cell surface like the wild-
type receptor. HeLa cells were transiently transfected with
either FLAG-tagged PAR1 wild type or mutant, and surface
receptor expression was assessed by ELISA. In both PAR1 wild
type- and Y383A/L386A mutant-transfected cells, a similar
amount of receptor was detected on the cell surface at steady
state (Fig. 1B), suggesting that these mutations did not alter
the amount of PAR1 surface expression. PAR1 couples to Gq
and stimulates phosphoinositide (PI) hydrolysis through the
activation of PLC- (21). Thus, to ensure that mutation of
tyrosine 383 and leucine 386 did not globally disrupt PAR1
signaling responses, we assessed agonist-induced PI hydroly-
sis. HeLa cells transiently expressing similar amounts of sur-
face PAR1 wild type or mutant were labeled with [myo-3H]-
inositol and incubated in the absence or presence of a saturat-
ing concentration of peptide agonist SFLLRN for 60 min at
37 °C. The accumulation of cellular [3H]IPs was then meas-
ured. In both PAR1 wild type- and mutant-expressing cells,
agonist induced a similar 6-fold increase in [3H]IP accumu-
lation compared with vector-transfected control cells (Fig. 1C).
Together, these findings suggest that mutation of PAR1 C-tail
residues tyrosine 383 and leucine 386 does not globally alter
receptor surface expression or signaling responses.
PAR1 Y383A/L386A Mutant Is Defective in Agonist-induced
Degradation—Activated PAR1 is internalized, sorted predom-
inantly to lysosomes, and rapidly degraded (11, 16). To deter-
mine whether PAR1 wild type and Y383A/L386A mutant are
sorted similarly to a degradative pathway upon activation,
transiently transfected HeLa cells were incubated in the ab-
sence or presence of agonist for 90 min at 37 °C. Cell lysates
were prepared and immunoprecipitated, and the amount of
PAR1 protein remaining was determined by immunoblot. In
FIG. 1. Identification of a highly conserved tyrosine-based mo-
tif, YXXL, in the C-tail of PAR1. A, amino acid sequence alignment of
PAR1 C-tail regions from various species cloned to date. The positions
of the amino acids shown are indicated by numbers in brackets. Note
that the tyrosine and leucine residues are conserved in all species. The
cytoplasmic tail of 2-adrenergic receptor lacks such a tyrosine-based
motif. B, HeLa cells transiently transfected with FLAG-tagged PAR1
wild type, Y383A/L386A mutant, or pcDNA vector were fixed, and the
steady-state amounts of cell surface receptors were determined by
ELISA. The data represent the mean  S.E., n  3. C, HeLa cells
transiently expressing similar amounts of surface PAR1 wild type or
Y383A/L386A mutant were labeled with [myo-3H]inositol and incu-
bated in the absence or presence of 50 M SFLLRN for 60 min at 37 °C.
The amounts of [3H]IPs formed were then measured. The basal levels of
[3H]IPs measured in PAR1 wild type-, Y383A/L386A mutant-, and
pcDNA vector-transfected cells were 353  34, 301  11, and 290  60
cpm, respectively. The data shown are the mean  S.D. for triplicates
in one experiment and are representative of three independent
experiments.
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untreated control cells, analysis of immunoprecipitates from
wild-type and mutant receptor lysates revealed comparable
amounts of one major PAR1 transfection-dependent band mi-
grating at 64 kDa (Fig. 2). Incubation with agonist peptide
SFLLRN caused a significant decrease in PAR1 wild-type pro-
tein; a 40% decrease in receptor protein was detected com-
pared with untreated control cells. These data suggest that
upon activation, PAR1 is internalized and rapidly sorted to a
degradative pathway in these cells, consistent with that previ-
ously reported (16). In striking contrast, in cells expressing the
PAR1 Y383A/L386A mutant, exposure to agonist peptide had a
minimal effect on receptor degradation (Fig. 2); only 15%
decrease of mutant receptor protein was observed compared
with control cells. At face value, these findings suggest that the
PAR1 C-tail tyrosine 383 and leucine 386 are critical residues
involved in the regulation of agonist-induced receptor
trafficking.
Activated PAR1 Internalization Is Regulated by a C-tail Lo-
calized YXXL Motif—To determine whether defective degrada-
tion of activated PAR1 Y383A/L386A mutant is due to inhibi-
tion of receptor internalization, we examined agonist-induced
loss of mutant receptor from the cell surface. HeLa cells tran-
siently transfected with either FLAG-PAR1 wild type or
Y383A/L386A mutant were incubated with agonist peptide
SFLLRN for various times at 37 °C. After incubations, cells
were fixed, and the amount of PAR1 remaining on the cell
surface was quantitated by ELISA and used as a measure of
receptor internalization. In these experiments, the amount of
PAR1 detected on the cell surface before incubation (0 min time
point) was similar for each transfection condition. In cells ex-
pressing PAR1 wild type, agonist induced rapid receptor inter-
nalization within 10 min (Fig. 3A). The wild-type receptor
continued to slowly internalize leading to a 60% loss of sur-
face PAR1 detected after 30 min of agonist exposure (Fig. 3A).
By contrast, in cells expressing PAR1 Y383A/L386A mutant,
the addition of agonist caused a more modest 25% decrease in
cell surface receptor that reached near steady state by 10 min
(Fig. 3A). The concentration effect for SFLLRN at inducing
PAR1 wild type and Y383A/L386A mutant internalization is
consistent with a defect in agonist-induced internalization of
mutant receptor (Fig. 3B). HeLa cells transiently expressing
PAR1 wild type or Y383A/L396A mutant were incubated with
varying concentrations of SFLLRN for 30 min at 37 °C, and the
amount of receptor remaining on the cell surface was then
measured. The maximal effect of 300 M SFLLRN at inducing
loss of PAR1 wild type and mutant from the cell surface was
60 and 28%, respectively. Together, these data suggest a
role for the tyrosine-based motif in agonist-induced PAR1
internalization.
The modest loss of agonist-induced PAR1 Y383A/L386A mu-
tant from the cell surface appears to be caused by defective
internalization. However, it is also possible that mutant PAR1
is normally internalized but recycled back to the cell surface
rather than sorted to lysosomes like the wild-type receptor. To
distinguish between these possibilities we followed internaliza-
tion and recycling of wild type and mutant receptor bound to
antibody (Fig. 4). HeLa cells transiently expressing FLAG-
tagged PAR1 wild type or Y383A/L386A mutant were incu-
bated with the calcium-dependent M1-FLAG antibody for 60
min at 4 °C, then washed to remove unbound antibody, and
incubated for 90 min at 37 °C in the absence or presence of
agonist. After incubation, surface-bound antibody and agonist
were removed by washing cells with PBS/EDTA, and the reap-
FIG. 2. A PAR1 Y383A/L386A mutant is defective in agonist-
induced receptor degradation. HeLa cells transiently transfected
with FLAG-PAR1 wild type or Y383A/L386A mutant were incubated in
absence or presence of 50 M SFLLRN for 90 min at 37 °C. PAR1 was
immunoprecipitated from equivalent amount of cell lysates and de-
tected by immunoblotting with an anti-PAR1 antibody. PAR1 appeared
as a prominent 64 kDa protein in transfected cells, whereas no protein
was detected in untransfected (UT) control cell lysates. Data in the bar
graph are expressed as the fraction of PAR1 remaining in agonist-
treated cells compared with untreated control cells and were quanti-
tated by Fluor-S Imager. The data are represented as the mean  S.E.
of three separate experiments. The difference in agonist-induced PAR1
wild-type degradation compared with Y383A/L386A mutant degrada-
tion was significant (*, p  0.01). Statistical analysis was determined
using an unpaired Student’s t test.
FIG. 3. Agonist-triggered PAR1 Y383A/L386A mutant internal-
ization is impaired. A, HeLa cells transiently expressing PAR1 wild
type or Y383A/L386A mutant were incubated with or without 50 M
SFLLRN peptide agonist for various times at 37 °C. Cells were then
fixed, and the amounts of receptor remaining on the cell surface were
quantitated by ELISA. The initial level of PAR1 wild type or mutant
expressed on the cell surface before incubation at 37 °C (0 min time)
was similar for each transfection condition. The results are expressed as
a fraction of total antibody bound to untreated control cells, shown as
the mean  S.E., and representative of three independent experiments
performed in triplicate. B, the concentration effect curves of SFLLRN at
inducing PAR1 wild type or Y383A/L386A mutant internalization were
determined in transiently transfected HeLa cells after 30 min of agonist
incubation at 37 °C. The data shown are the mean  S.D. for triplicates
in one experiment and are representative of at least three separate
experiments.
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pearance of previously internalized receptor-bound M1 FLAG
antibody was followed over the next 60 min. The amount of
antibody on the cell surface at various times was then quanti-
tated by ELISA. A prolonged 90-min exposure to agonist pep-
tide caused a substantial decrease in the amounts of surface
PAR1 wild type and Y383A/L386A mutant (Fig. 4, A and B). By
contrast, the addition of SFLLRN to cells expressing the P/S
C-tail, a chimeric PAR1 bearing the C-tail of the substance P
receptor, caused only a more modest 20% loss of cell surface
receptor (Fig. 4C), consistent with internalization and recycling
of this receptor previously reported (11).
After this initial agonist incubation, antibody was stripped
from the cell surface with PBS/EDTA, and the recovery of
internalized receptor-antibody complex was followed. In
PAR1 wild type-expressing cells, a modest amount of recov-
ery was observed in cells treated with or without agonist
despite the large cohort of receptor-bound antibody internal-
ized by agonist (Fig. 4A). Similarly, in cells expressing the
PAR1 Y383A/L386A mutant only a small amount of recovery
was seen in cells incubated in either the presence or absence
of agonist (Fig. 4B). These results are consistent with the
extent of constitutive internalization and recycling of PAR1
wild type previously described (10). In contrast, P/S C-tail
expressing cells showed some recovery in cells that had not
been pretreated with agonist; however, a greater amount of
recovery of antibody was detected on the cell surface of ago-
nist-treated cells (Fig. 4C), consistent with agonist-depend-
ent internalization and recycling of P/S C-tail chimera (11).
Together, these observations suggest that PAR1 Y383A/
L386A mutant is not aberrantly recycled to the cell surface
after agonist exposure and are instead consistent with a
defect in agonist-induced internalization.
A PAR1 Mutant Lacking the C-tail Region Distal to the YXXL
Motif Constitutively Internalizes—PAR1 C-tail phosphoryla-
tion is critical for agonist-induced receptor internalization in
multiple cell types (10, 13). To determine whether the distal
C-tail region containing the major sites of phosphorylation is
critical for internalization, a PAR1 truncation mutant lacking
the last 39 amino acids beyond the YXXL motif was generated
by introducing a stop codon at cysteine 387 (C387Z). We ini-
tially examined cell surface expression of PAR1 C387Z trunca-
tion mutant in transiently transfected HeLa cells. To our sur-
prise, we observed a significant decrease in steady state
amounts of surface PAR1 C387Z mutant compared with wild-
type receptor (Fig. 5A). Interestingly, however, a PAR1 C387Z
truncation mutant in which the critical tyrosine 383 and
FIG. 4. Agonist-independent constitutive internalization and
recycling of PAR1 Y383A/L386A mutant is unaffected. HeLa cells
expressing similar amounts of surface FLAG-tagged PAR1 wild type
(A), Y383A/L386A mutant (B), or the P/S C-tail chimera (C) were
labeled with M1 anti-FLAG antibody for 1 h at 4 °C. Unbound antibody
was washed away, and cells were incubated in the absence or presence
of 50 M SFLLRN for 90 min at 37 °C. Surface-bound antibody was then
removed with PBS, 0.04% EDTA, and the amount of receptor-bound
antibody reappearing at the cell surface was measured after 0, 30, and
60 min of recovery time. Surface-bound antibody was quantitated by
ELISA after the initial 4 °C incubation (t0), after 37 °C incubation in
the absence or presence of agonist (t1) and after the indicated times of
recovery. The data are expressed as (amount of surface-bound anti-
body detected at the indicated time points)/(surface-bound antibody
measured at t0). Similar results were observed in three different
experiments.
FIG. 5. Surface expression and signaling of PAR1 C387Z trun-
cation mutants. A, HeLa cells were transiently transfected with the
same amounts of plasmids encoding either FLAG-tagged PAR1 wild
type, C387Z mutants, or pcDNA vector. After 48 h of transfection, cells
were fixed, and the amount of receptor expressed at the cell surface was
measured by ELISA. The data (mean  S.D., n  3) shown are repre-
sentative of three independent experiments. B, HeLa cells transiently
expressing FLAG-PAR1 wild type or C387Z mutants labeled with [myo-
3H]inositol were incubated in the absence or presence of 50 M SFLLRN
for 60 min at 37 °C. The amounts of [3H]IPs formed were then meas-
ured. The data are shown as mean  S.D., n  3, and expressed as -fold
increase over basal [3H]IPs and normalized to total receptor expression.
Similar results were observed in three independent experiments.
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leucine 386 were converted to alanine (C387Z-Y383A/L386A)
displayed cell surface expression levels comparable to wild-type
receptor (Fig. 5A). We next examined the signaling responses of
PAR1 C387Z truncation mutants to ensure that differences in
surface expression were not due to general disruption of recep-
tor function. Transiently transfected HeLa cells labeled with
[myo-3H]inositol were incubated in the absence or presence of
agonist for 60 min at 37 °C and the generation of [3H]IPs were
then measured. The stimulation of [3H]IP accumulation when
normalized to total receptor surface expression was comparable
for both PAR1 wild type and C387Z mutants (Fig. 5B). These
findings suggest that each activated PAR1 wild type and mu-
tant present at the cell surface is able to couple similarly to
PI hydrolysis.
To determine whether decreased cell surface expression of
PAR1 C387Z truncation mutant containing an intact tyrosine-
based motif is due to constitutive internalization, we assayed
the uptake of receptor-bound antibody over time. HeLa cells
were transiently transfected with 0.2, 0.8, or 0.1 g of plasmids
encoding either FLAG-tagged PAR1 wild type, C387Z mutant,
or C387Z-Y383A/L386A mutant, respectively, to achieve simi-
lar amounts of cell surface expression. Cells were then incu-
bated with M1 anti-FLAG antibody for 1 h at 4 °C; under these
conditions only receptors residing at the cell surface were la-
beled with antibody. Cells were then incubated in the absence
or presence of agonist at 37 °C for various times to allow inter-
nalization of receptor-bound antibody. After these incubations,
antibody remaining bound to the cell surface was removed by
washing with PBS/EDTA, cells were lysed and internalized
antibody was quantitated by ELISA. In untransfected cells, the
amount of antibody bound or internalized was negligible (data
not shown). In PAR1 wild type-expressing cells not exposed to
agonist, 20% of antibody initially bound to the cell surface
was internalized at steady state (Fig. 6A), consistent with tonic
cycling of the wild-type receptor as previously reported (10).
Agonist exposure caused a rapid and substantial 80% in-
crease in internalized wild-type PAR1-bound antibody by 10
min (Fig. 6A). In cells expressing PAR1 C387Z truncation mu-
tant with an intact YXXL motif, a significant 50% of inter-
nalized receptor-bound antibody was detected in the absence of
agonist. Interestingly, however, activation of PAR1 C387Z mu-
tant failed to cause an increase in the amount of receptor-
bound antibody uptake (Fig. 6A), suggesting that this mutant
receptor is internalized constitutively independent of agonist
stimulation. In contrast, PAR1 truncation mutant in which the
critical tyrosine and leucine residues were mutated to alanines
(C387Z-Y383A/L386A) failed to internalize in both agonist-
treated and untreated cells (Fig. 6A). Studies examining ago-
nist-induced loss of PAR1 wild type and C387Z truncation
mutants from the cell surface yielded similar results (Fig. 6B).
In PAR1 wild type-expressing cells, a 50% loss of surface
receptor was detected following 30 min of agonist exposure
(Fig. 6B). In contrast, agonist failed to induce significant loss of
constitutively internalized PAR1 C387Z mutant or internaliza-
tion defective PAR1 C387Z-Y383A/L386A mutant from the cell
surface compared with untreated control cells. Together, these
findings strongly suggest that an intact tyrosine-based motif is
both necessary and sufficient for internalization of a PAR1
mutant in which the C-tail regulatory domain has been deleted.
Degradation of PAR1 C387Z Truncation Mutant Is Inhibited
by Dominant-negative K44A Dynamin—We next determined
whether constitutively internalized PAR1 C387Z truncation
mutant is being degraded via a dynamin-dependent pathway.
Dynamin K44A mutant is defective in its GTPase activity and
functions as a dominant-negative protein to block endogenous
dynamin activity in HeLa cells (22). HeLa cells transiently
co-transfected with either FLAG-tagged PAR1 wild type or
C387Z mutants together with either dynamin wild type, K44A
mutant, or vector were incubated in the absence or presence of
agonist for 90 min at 37 °C. Cell lysates were prepared and
immunoprecipitated, and the presence of PAR1 was detected
by immunoblotting. In PAR1 wild type-expressing cells co-
transfected with either dynamin wild type or vector, exposure
to agonist caused a substantial 50% decrease in receptor
protein (Fig. 7A, lanes 3 and 5, upper panel). In contrast,
agonist-induced degradation of PAR1 wild type was virtually
abolished in cells co-expressing dynamin K44A mutant (Fig.
7A, lanes 6 and 7, upper panel), consistent with that previously
published (16). Interestingly, in cells co-transfected with PAR1
C387Z truncation mutant containing an intact YXXL motif and
wild-type dynamin only a modest amount of PAR1 C387Z pro-
tein was detected compared with wild-type PAR1 (Fig. 7A,
lanes 4 and 5, lower panel). A similar decrease in PAR1 C387Z
mutant was observed in vector-transfected cells (Fig. 7A, lanes
2 and 3, lower panel), suggesting that overexpression of wild-
type dynamin did not enhance degradation of PAR1 C387Z
mutant. Strikingly, however, co-expression of dynamin K44A
mutant significantly increased the amount of PAR1 C387Z
mutant protein to a level comparable to that observed with
wild-type PAR1 (Fig. 7A, lanes 6 and 7, lower panel). Interest-
ingly, the amount of PAR1 C387Z protein detected was not
FIG. 6. A PAR1 C387Z truncation mutant with an intact ty-
rosine-based motif constitutively internalizes. A, HeLa cells were
transiently transected with 0.2, 0.8 or 0.1 g of plasmid encoding either
FLAG-PAR1 wild type (WT), C387Z mutant, or C387Z Y383A/L386A
mutant, respectively, to achieve similar amounts of surface expression.
Cells were then incubated M1 anti-FLAG antibody for 1 h at 4 °C,
washed, and then incubated in the absence (dashed lines) or presence
(solid lines) of 50 M SFLLRN for various times at 37 °C. Antibody that
remained bound to the cell surface was removed by washing with PBS,
0.04% EDTA (M1 anti-FLAG antibody binding requires calcium), and
internalized antibody was measured by ELISA. Data (mean  S.D., n 
3) are expressed as a fraction of initial surface receptor-bound antibody,
defined as antibody binding to untreated cells not washed with PBS/
EDTA. Similar results were obtained in three independent experi-
ments. B, transiently transfected HeLa cells expressing similar
amounts of surface PAR1 wild type or C387Z mutants were incubated
with or without 50 M SFLLRN for 30 min at 37 °C. Cells were then
fixed, and the amount of PAR1 remaining on the cell surface was
measured by ELISA. The data (mean  S.E.) are averages of three
separate experiments performed in triplicate.
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affected by agonist exposure in all transfection conditions, sug-
gesting that the receptor is constitutively degraded in an ago-
nist-independent manner. However, mutation of the critical
tyrosine and leucine residues in the PAR1 truncation mutant
(C387Z-Y383A/L386A) abolished constitutive degradation of
the receptor mutant (Fig. 7B). Thus, the ability of dynamin
K44A mutant to inhibit constitutive degradation of PAR1
C387Z mutant strongly suggests that lysosomal sorting occurs
via a dynamin-dependent pathway. These findings further sug-
gest that an intact tyrosine-based motif is sufficient to promote
sorting of PAR1 to a degradative pathway when exposed at the
C terminus.
Constitutive Internalization of PAR1 C387Z Truncation Mu-
tant Is Inhibited by Dynamin K44A Dominant Negative—We
next examined whether dynamin K44A blocks PAR1 C387Z
mutant degradation by inhibiting constitutive receptor inter-
nalization. HeLa cells were transiently co-transfected with
PAR1 wild type or C387Z mutant together with either dynamin
wild type, K44A mutant, or vector, and the amounts of receptor
present on the cell surface were determined at steady state. In
cells expressing wild-type dynamin, a substantial amount of
PAR1 wild-type surface expression was detected compared
with C387Z mutant (Fig. 8). Similarly, a greater amount of
PAR1 wild type was present on the cell surface compared with
C387Z truncation mutant in vector-transfected cells (Fig. 8),
suggesting that wild-type dynamin did not induce loss of PAR1
C387Z mutant from the cell surface. Strikingly, however, a
comparable amount of PAR1 wild type and C387Z mutant was
measured on the surface of cells co-expressing K44A mutant
dynamin (Fig. 8). The apparent decrease in surface PAR1 wild
type in cells co-expressing K44A mutant compared with control
cells is likely caused by receptor being trapped in deeply invag-
inated coated pits formed by the action of dominant-negative
dynamin (Fig. 8) (16). Such trapped surface receptors are most
likely not accessible to antibody and therefore cause an under-
estimation of the total receptor present at the cell surface.
Together, these findings suggest that PAR1 C387Z mutant
containing an intact tyrosine-based motif is constitutively in-
ternalized through a dynamin-dependent pathway.
Immunofluorescence confocal microscopy studies are con-
sistent with a dynamin-dependent constitutive internaliza-
tion of PAR1 C387Z truncation mutant. In cells expressing
wild-type GFP-tagged dynamin, exposure to agonist for 10
min at 37 °C caused internalization of wild-type PAR1-bound
antibody into endocytic vesicles, whereas virtually no inter-
nalized receptor was detected in untreated control cells (Fig.
9A). In contrast, PAR1 C387Z mutant redistributed to dis-
tinct endocytic vesicles in dynamin wild type-expressing cells
treated with or without agonist (Fig. 9B). Similar results
were seen in untransfected cells, suggesting that wild-type
dynamin did not induce constitutive internalization of PAR1
C387Z mutant (Fig. 9B, arrows). Agonist-triggered internal-
ization of PAR1 wild type was abolished in cells expressing
GFP-dynamin K44A mutant, whereas in adjacent untrans-
fected cells, endocytic vesicles containing PAR1 were clearly
evident (Fig. 9C). Interestingly, mutant dynamin K44A also
blocked constitutive internalization of PAR1 C387Z mutant;
however, adjacent untransfected cells showed robust PAR1
C387Z internalization even in the absence of agonist (Fig.
9D). In contrast, PAR1 C387Z mutant in which tyrosine 383
and leucine 386 were converted to alanine remained localized
FIG. 8. Dominant-negative K44A dynamin mutant blocks con-
stitutive loss of PAR1 C387Z mutant from the cell surface. HeLa
cells were transiently co-transfected with FLAG-PAR1 wild type (WT)
or C387Z truncation mutant and either dynamin wild type (Dyn WT),
K44A mutant, or pcDNA vector. After 48 h of transfection, cells were
fixed, and the amount of receptor expressed on the cell surface at steady
state was measured by ELISA. The data are expressed as the mean 
S.D., n  3 and are representative of three individual experiments.
FIG. 7. Effect of dominant-negative
K44A dynamin on agonist-induced
PAR1 wild type and C387Z mutant
degradation. A, HeLa cells transiently
transfected with the same amounts of
plasmids encoding FLAG-tagged PAR1
wild type or C387Z mutant together with
either dynamin wild type (Dyn Wt), K44A
mutant, or pcDNA were incubated in the
absence or presence of 50 M SFLLRN for
90 min at 37 °C. An equivalent amount of
cell lysates was then immunoprecipitated
with M2 anti-FLAG antibody, and PAR1
was detected by immunoblot using an an-
ti-PAR1 antibody. One prominent protein
migrating at 64 kDa was detected in
PAR1 wild type (upper panel)- and C387Z
mutant (lower panel)-transfected cells. No
protein was detected in pcDNA vector-
transfected control lysates (lane 1). Data
shown are representative of three inde-
pendent experiments. B, transiently
transfected HeLa cells expressing PAR1
wild type (WT) or C387Z-Y383A/L386A
mutant were incubated with or without
50 M SFLLRN for 90 min at 37 °C and
processed as described above. A 64 kDa
protein was detected in PAR1-transfected
cells but not in untransfected (UT) control
cells. Similar results were observed in
three independent experiments.
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to the cell surface even after agonist incubation (data not
shown). Taken together with the results described above,
these observations strongly suggest that PAR1 C387Z mu-
tant bearing an intact YXXL motif is constitutively internal-
ized and degraded via a dynamin-dependent pathway.
The PAR1 C387Z-Y383A/L386A Mutant Is Defective in Sig-
nal Termination—In addition to phosphorylation and arrestin
binding (13, 14), internalization and lysosomal sorting of acti-
vated PAR1 is also critical for termination of receptor signaling
(11). To determine whether PAR1 C387Z truncation mutants
are defective in signal termination we examined shut off of PI
hydrolysis in cells (15). To achieve similar amounts of receptor
surface expression, HeLa cells were transiently transfected
with 0.2, 0.8, or 0.1 g of cDNA plasmids encoding PAR1 wild
type, C387Z mutant, or C387Z-Y383A/L386A mutant, respec-
tively (Fig. 10A). Cells were labeled with [myo-3H]inositol and
then incubated with 10 nM -thrombin for 60 min at 37 °C in
the absence or presence of lithium chloride, an inhibitor of
inositol phosphate phosphatases. In the presence of lithium
chloride, -thrombin stimulated comparable amounts of [3H]IP
accumulation in cells expressing PAR1 wild type or C387Z
truncation mutants (Fig. 10B). In the absence of lithium chlo-
ride, activated receptors stimulate PI hydrolysis but [3H]IPs
are rapidly metabolized and do not accumulate even after 60
min of agonist exposure (Fig. 10C). After agonist removal from
cells, lithium chloride was added to allow accumulation of any
[3H]IPs generated by ongoing PI hydrolysis. In cells expressing
PAR1 wild type or C387Z mutant, no IPs were detectable over
a 60-min time period suggesting that receptor signaling had
shut off completely after agonist removal (Fig. 10C). In con-
trast, however, the rate of [3H]IP accumulation observed in
cells expressing PAR1 C387Z-Y383A/L386A mutant was com-
parable to that observed in cells when agonist and lithium
chloride were added simultaneously (Fig. 10, B and C). These
data suggest that proteolytically activated PAR1 C387Z-
Y383A/386A mutant signals persistently in the absence of ag-
onist and lend further support for the idea that internalization
is critical for termination of signaling by proteolytically acti-
vated PAR1.
DISCUSSION
We previously reported that activated PAR1 internalized
through a clathrin- and dynamin-dependent pathway, inde-
pendent of arrestins (13). Interestingly, however, phosphoryl-
ation of the C-tail region of PAR1 was still essential for agonist-
triggered receptor internalization. Toward understanding the
mechanisms responsible for activated PAR1 recruitment to
clathrin-coated pits and internalization from the plasma mem-
brane we examined the function of a C-tail localized highly
conserved tyrosine-based motif in receptor trafficking. Our
FIG. 9. Effect of dominant-negative dynamin K44A mutant on PAR1 wild type and C387Z mutant internalization examined by
immunofluorescence microscopy. A–D, HeLa cells were transiently co-transfected with FLAG-PAR1 wild type (WT) or C387Z mutant and
either GFP-tagged dynamin (Dyn) wild type or K44A dominant-negative mutant. Cells were then incubated in the absence (Ctrl) or presence of 50
M SFLLRN for 10 min at 37 °C. Cells were immunostained for PAR1, and then imaged by immunofluorescence confocal microscopy. C, PAR1
C387Z mutant redistributed to endocytic vesicles in both GFP-dynamin-transfected cells and untransfected control cells even in the absence of
agonist (arrows). D, note the absence of PAR1 C387Z mutant-containing endocytic vesicles in both agonist-treated and untreated cells expressing
dynamin K44A mutant (arrows) and the presence of such vesicles in adjacent untransfected cells. These imaged cells are representative of many
cells examined in two independent experiments. The scale bar denotes 10 m.
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findings strongly suggest that agonist-stimulated PAR1 inter-
nalization is also regulated by a tyrosine-based motif. A PAR1
mutant in which the critical tyrosine 383 and leucine 386 were
converted to alanines was significantly impaired in agonist-
induced internalization. Consistent with a decrease in mutant
PAR1 internalization, a concomitant inhibition of agonist-trig-
gered receptor degradation was also observed. In contrast, ag-
onist-independent constitutive internalization and recycling of
unactivated PAR1 mutant remained intact. Moreover, a PAR1
truncation mutant in which the YXXL motif was exposed at the
C terminus yielded a receptor that constitutively internalized
and down-regulated in an agonist-independent but dynamin-
dependent manner. These results strongly suggest that the
tyrosine-based motif functions as a trafficking signal for acti-
vated PAR1. Together, these findings raise the distinct possi-
bility that agonist-triggered PAR1 internalization is regulated
by multiple mechanisms including C-tail phosphorylation and
a highly conserved tyrosine-based motif.
In the classic paradigm, activated GPCRs are phosphoryl-
ated and bind arrestins, which facilitate receptor interaction
with components of the clathrin endocytic machinery. In con-
trast, activated PAR1 is phosphorylated and recruited to clath-
rin-coated pits independent of arrestin binding (13). A PAR1
C-tail mutant, in which all serines and threonines were re-
placed with alanines, is defective in agonist-induced phospho-
rylation and fails to internalize in multiple cell types (10). In
addition, a PAR1 C-tail truncation mutant Y397Z lacking the
distal C-terminal portion of the C-tail is also impaired in ago-
nist-triggered phosphorylation and internalization (10). Inter-
estingly, however, activated PAR1 C-tail phosphorylation oc-
curs at multiple regulatory sites any of which is sufficient for
internalization (17). These findings suggest that phosphoryla-
tion of the C-tail of PAR1 is the major initiating event respon-
sible for receptor endocytosis. In addition to phosphorylation,
our results suggest that a highly conserved tyrosine-based mo-
tif also functions in agonist-induced PAR1 internalization. It is
possible that activated PAR1 C-tail phosphorylation induces a
conformational change in the receptor that exposes the YXXL
motif and thereby facilitates receptor internalization. Indeed,
removal of the C-tail region of PAR1 distal to the YXXL motif
containing the major sites of phosphorylation resulted in con-
stitutive receptor internalization, whereas a truncation mutant
in which the critical tyrosine and leucine were converted to
alanine failed to internalize. Consistent with these findings,
agonist-induced C-tail phosphorylation of the -opioid GPCR is
essential for internalization, whereas agonist-stimulated inter-
nalization of truncation mutants appears to occur independent
of receptor phosphorylation (23). These findings raise the pos-
sibility that agonist-induced phosphorylation of the C-tail re-
gion of GPCRs removes an inhibitory signal and thereby ex-
poses a positive signal that controls the initial endocytosis of
these receptors.
Several specific sorting signals used for clathrin-dependent
endocytosis have been identified in the cytoplasmic tails of
transmembrane proteins including a tyrosine-based motif,
YXX (where Y denotes tyrosine, X is any amino acid, and  is
an amino acid with a bulky hydrophobic side group) (24). The
activity of this type of sorting signal requires that the critical
tyrosine be in an unphosphorylated state. In some cases, ty-
rosine-based motifs function purely as endocytic signals and
are most often found 10–40 residues from the transmembrane
domains, but not at the C terminus. The highly conserved
YXXL motif found within the C-tail region of PAR1 resides 10
amino acids from the seventh transmembrane domain and
mutation of the critical tyrosine 383 and leucine 386 residues
significantly impairs agonist-induced receptor endocytosis. In
addition to their endocytic function, tyrosine-based motifs have
been implicated in targeting of transmembrane proteins to
lysosomes. Interestingly, however, lysosomal targeting signals
are often found 6–9 resides from the transmembrane domain
and at the C terminus of proteins (24). We have found that the
PAR1 C387Z truncation mutant containing a C-terminal YXXL
motif is constitutively internalized and degraded independent
of agonist, suggesting that this signal functions not only in
internalization but also promotes lysosomal sorting of the re-
ceptor. However, we cannot exclude the possibility that we
have inadvertently converted the PAR1 YXXL motif from a
predominantly endocytic signal to a lysosomal sorting signal by
changing its position relative to the C terminus. Regardless,
our data strongly suggest a role for the tyrosine-based motif in
agonist-triggered trafficking of PAR1.
The adaptor protein complex-2 (AP-2) interacts with YXX
signals within the cytoplasmic tails of transmembrane proteins
FIG. 10. Persistent signaling by PAR1 C387Z-Y383A/L386A mu-
tant after activation with thrombin. HeLa cells were transiently
transfected with 0.2, 0.8, or 0.1 g of cDNA plasmid encoding either
PAR1 wild type (WT), C387Z mutant, or C387Z-Y383A/L386A mutant
to yield similar amounts of receptor expressed at the cell surface. A,
cells were fixed, and the surface receptor expression was measured by
ELISA. B, cells labeled with [myo-3H]inositol were incubated in the
absence or presence of 10 nM -thrombin for 60 min at 37 °C in lithium
chloride-containing medium. The data are expressed as -fold increase
over basal [3H]IPs detected in untreated control cells. C, HeLa cells
expressing comparable amounts of surface PAR1 wild type (WT), C387Z
mutant, or C387Z-Y383A/L386A mutant were incubated with 10 nM
-thrombin for 60 min at 37 °C in the absence of lithium chloride.
Agonist was removed, and cells were washed three times with DMEM
containing 0.5 units/ml hirudin, an -thrombin inhibitor. Cells were
then incubated with DMEM containing 20 mM lithium chloride and 0.5
units/ml hirudin at 37 °C for an additional 60 min, at which time
accumulated [3H]IPs were measured. The data are expressed as the
-fold increase over basal [3H]IPs accumulated in untreated control cells.
Similar results were obtained in three separate experiments.
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and thereby facilitates recruitment to clathrin-coated pits at
the plasma membrane. AP-2 is a heterotetrameric complex
composed of two large subunits ( and 2) and two smaller
subunits (2 and 2). The 2 subunit binds directly to tyrosine-
based sorting signals. Indeed, in preliminary work, using the
yeast two-hybrid system, we found that 2 binds directly to the
C-tail of PAR1.2 Thus, unmasking the YSIL motif, perhaps by
a phosphorylation-induced conformation change of the C-tail
following PAR1 activation, could facilitate receptor interaction
with 2 of the AP-2 complex and internalization from the
plasma membrane. The AP-2 complex has been implicated in
GPCR trafficking through both direct and indirect interactions
with the receptors. The 1b-adrenergic receptor binds 2 of the
AP-2 complex directly through a non-canonical motif consisting
of eight consecutive arginines; mutation of this motif impairs
agonist-induced internalization and binding of 2 to the recep-
tor (25). Interestingly, multiple YXX sorting motifs are found
within the cytoplasmic domains of the 1b-adrenergic receptor;
however, their function remains to be determined. In addition,
AP-2 can bind to di-leucine-based sorting signals through a
distinct site from that utilized for YXX motifs (24). A di-
leucine-based motif is important for the phosphorylation inde-
pendent agonist-induced internalization of the chemokine re-
ceptor CXCR2, a receptor, which can directly interact with the
2- and 2-adaptin components of AP-2 (26). However, whether
AP-2 functions in regulated trafficking of CXCR2 is not known.
Finally, AP-2 has been shown to function indirectly in endocy-
tosis of the 2-adrenergic receptor through interactions with
arrestins, which can bind to the 2 subunit of the AP-2 complex
(27, 28).
To determine whether YXX motifs are unique to a few
GPCRs or whether such motifs are commonly found in the
cytoplasmic tails of these receptors we examined the C-tail
regions of all predicted human GPCRs for such motifs (see Fig.
11 in Supplemental Data). Interestingly, sequences conforming
to the YXX are common in the C-tail region of many GPCRs
including receptors that are activated by peptides. These find-
ings raise the exciting possibility that YXX could serve di-
verse functions in GPCR trafficking including endocytosis, ly-
sosomal sorting or basolateral targeting in polarized cells.
However, it remains to be determined whether these sequences
are active as sorting signals or whether they remain inactive
because they are folded within the protein structure and there-
fore are inaccessible for interactions with adaptor sorting mol-
ecules. Surprisingly, these analyses also revealed a second
tyrosine-based motif YKKL located close to the C terminus of
the PAR1, whether this motif functions in PAR1 trafficking is
not known.
The findings in this study reveal that internalization of ac-
tivated PAR1 is controlled by multiple regulatory mechanisms
including C-tail phosphorylation and a highly conserved ty-
rosine-based motif, YXXL. A PAR1 mutant in which the critical
tyrosine 383 and leucine 386 residues were converted to ala-
nines was significantly impaired in agonist-induced receptor
internalization, whereas constitutive internalization and recy-
cling remained intact. A PAR1 truncation mutant that con-
tained an intact tyrosine-based motif at the C terminus consti-
tutively internalized and degraded, whereas a mutant in which
the critical tyrosine and leucine were replaced with alanines
failed to internalize. These findings demonstrate for the first
time a role for a tyrosine-based motif, YXX, in GPCR traffick-
ing. We examined whether PAR1 mutants defective in traffick-
ing had a functional correlate. Internalization defective PAR1
C387Z-Y383A/L386A displayed persistent signaling long after
thrombin removal, in marked contrast to the efficient termina-
tion of signaling by wild-type PAR1 in the same cells. These
findings suggest that internalization of proteolytically acti-
vated PAR1 is critical for the temporal fidelity of thrombin
signaling in cells. Together, our results suggest that internal-
ization of proteolytically activated PAR1 through clathrin-
coated pits proceeds via a novel mechanism involving a ty-
rosine-based motif. AP-2 binds to YXX motifs localized in the
cytoplasmic regions of many transmembrane proteins and fa-
cilitates recruitment to clathrin-coated pits. It remains to be
determined whether AP-2 functions in the regulation of
PAR1 trafficking.
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